Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
21
FLGC Quote, Financials, Valuation and Earnings
Last price:
$1.05
Seasonality move
:
11.22%
Day range:
$0.96 - $1.10
52-week range:
$0.75 - $2.93
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.18x
P/B ratio:
4.23x
Volume:
847.9K
Avg. volume:
748K
1-year change:
-21.21%
Market cap:
$18M
Revenue:
$76.1M
EPS (TTM):
-$1.69
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $106K | $9M | $33.4M | $76.1M | |
| Revenue Growth (YoY) | -- | -- | 8371.7% | 271.95% | 127.75% | |
| Cost of Revenues | -- | $35K | $6.6M | $20.2M | $58.3M | |
| Gross Profit | -- | $71K | $2.4M | $13.3M | $17.7M | |
| Gross Profit Margin | -- | 66.98% | 27.01% | 39.67% | 23.32% | |
| R&D Expenses | -- | $78K | $132K | $388K | $62K | |
| Selling, General & Admin | -- | $11.8M | $17.8M | $28.8M | $23.3M | |
| Other Inc / (Exp) | -- | -$1.8M | -$3.8M | -$27.6M | -$37.6M | |
| Operating Expenses | -- | $12.5M | $20M | $33.8M | $28.3M | |
| Operating Income | -- | -$12.5M | -$17.6M | -$20.5M | -$10.6M | |
| Net Interest Expenses | -- | $30K | $32K | -- | $92K | |
| EBT. Incl. Unusual Items | -- | -$14.3M | -$21.5M | -$48.1M | -$48.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -$5.9M | -$9.7M | |
| Income Tax Expense | -- | -- | -$98K | -$1.4M | -$1.6M | |
| Net Income to Company | -- | -$14.3M | -$21.4M | -$52.6M | -$56.3M | |
| Minority Interest in Earnings | -- | $164K | $112K | $214K | -$689K | |
| Net Income to Common Excl Extra Items | -- | -$14.2M | -$21.2M | -$52.4M | -$57M | |
| Basic EPS (Cont. Ops) | -- | -$6.74 | -$9.60 | -$13.68 | -$7.75 | |
| Diluted EPS (Cont. Ops) | -- | -$6.74 | -$9.60 | -$13.68 | -$7.75 | |
| Weighted Average Basic Share | -- | $2.1M | $2.2M | $3.8M | $7.4M | |
| Weighted Average Diluted Share | -- | $2.1M | $2.2M | $3.8M | $7.4M | |
| EBITDA | -- | -$14.2M | -$20.9M | -$17.9M | -$45.7M | |
| EBIT | -- | -$14.3M | -$21.4M | -$20.5M | -$48.2M | |
| Revenue (Reported) | -- | $106K | $9M | $33.4M | $76.1M | |
| Operating Income (Reported) | -- | -$12.5M | -$17.6M | -$20.5M | -$10.6M | |
| Operating Income (Adjusted) | -- | -$14.3M | -$21.4M | -$20.5M | -$48.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $2.1M | $9.7M | $17.3M | $12.5M | |
| Revenue Growth (YoY) | -- | -- | 363.78% | 78.4% | -28.02% | |
| Cost of Revenues | -- | $1.5M | $5M | $12.4M | $9.6M | |
| Gross Profit | -- | $619K | $4.7M | $4.9M | $2.8M | |
| Gross Profit Margin | -- | 29.58% | 48.24% | 28.54% | 22.78% | |
| R&D Expenses | -- | -$20K | $79K | $8K | $118K | |
| Selling, General & Admin | -- | $3.8M | $7.1M | $4.5M | $5.3M | |
| Other Inc / (Exp) | -- | $38K | -$2.9M | $1.1M | -$705K | |
| Operating Expenses | -- | $4.2M | $8.4M | $5.5M | $6.1M | |
| Operating Income | -- | -$3.6M | -$3.7M | -$554K | -$3.2M | |
| Net Interest Expenses | -- | $57K | -- | $16K | $27K | |
| EBT. Incl. Unusual Items | -- | -$3.6M | -$6.7M | $579K | -$4M | |
| Earnings of Discontinued Ops. | -- | -- | -$737K | $492K | -- | |
| Income Tax Expense | -- | -- | -- | -$51K | -$164K | |
| Net Income to Company | -- | -- | -$7.4M | $1.1M | -$3.8M | |
| Minority Interest in Earnings | -- | $23K | $30K | $115K | $27K | |
| Net Income to Common Excl Extra Items | -- | -$3.6M | -$7.4M | $1.2M | -$3.8M | |
| Basic EPS (Cont. Ops) | -- | -$1.60 | -$1.93 | $0.18 | -$0.28 | |
| Diluted EPS (Cont. Ops) | -- | -$1.60 | -$1.93 | $0.16 | -$0.28 | |
| Weighted Average Basic Share | -- | $2.2M | $3.8M | $6.9M | $13.4M | |
| Weighted Average Diluted Share | -- | $2.2M | $3.8M | $7.6M | $13.4M | |
| EBITDA | -- | -$3.5M | -$3.1M | $901K | -$3.7M | |
| EBIT | -- | -$3.6M | -$3.7M | $595K | -$3.9M | |
| Revenue (Reported) | -- | $2.1M | $9.7M | $17.3M | $12.5M | |
| Operating Income (Reported) | -- | -$3.6M | -$3.7M | -$554K | -$3.2M | |
| Operating Income (Adjusted) | -- | -$3.6M | -$3.7M | $595K | -$3.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $28.4M | $68.6M | $64.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $16.9M | $51.4M | $50.8M | |
| Gross Profit | -- | -- | $11.5M | $17.3M | $13.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $66K | $467K | $112K | $252K | |
| Selling, General & Admin | -- | $10.2M | $31.5M | $24.5M | $20.8M | |
| Other Inc / (Exp) | -- | $161K | -$24.2M | -$40M | -$6.8M | |
| Operating Expenses | -- | $11.3M | $37.4M | $30.1M | $23.9M | |
| Operating Income | -- | -$10.3M | -$26M | -$12.8M | -$10.6M | |
| Net Interest Expenses | -- | $78K | -- | $85K | $49K | |
| EBT. Incl. Unusual Items | -- | -$10.2M | -$50M | -$52.9M | -$17.4M | |
| Earnings of Discontinued Ops. | -- | -- | -$2.3M | -$10M | -$1.9M | |
| Income Tax Expense | -- | -- | -$98K | -$2.7M | -$452K | |
| Net Income to Company | -- | -- | -- | -$60.3M | -$18.8M | |
| Minority Interest in Earnings | -- | $42K | $101K | $489K | -$1M | |
| Net Income to Common Excl Extra Items | -- | -$10.2M | -$52.2M | -$59.8M | -$19.9M | |
| Basic EPS (Cont. Ops) | -- | -$4.71 | -$15.95 | -$10.01 | -$1.69 | |
| Diluted EPS (Cont. Ops) | -- | -$4.71 | -$15.95 | -$10.03 | -$1.69 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -$10M | -$27.5M | -$9.8M | -$17M | |
| EBIT | -- | -$10.1M | -$29.8M | -$12.6M | -$17.8M | |
| Revenue (Reported) | -- | -- | $28.4M | $68.6M | $64.2M | |
| Operating Income (Reported) | -- | -$10.3M | -$26M | -$12.8M | -$10.6M | |
| Operating Income (Adjusted) | -- | -$10.1M | -$29.8M | -$12.6M | -$17.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $3.3M | $23.6M | $58.1M | $46.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $2.2M | $12.9M | $43.8M | $36.3M | |
| Gross Profit | -- | $1.1M | $10.7M | $14.2M | $9.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $25K | $41K | $400K | $37K | $227K | |
| Selling, General & Admin | $1.5M | $7M | $23.4M | $17.8M | $15.2M | |
| Other Inc / (Exp) | $127K | $34K | -$20.4M | -$32.7M | -$1.9M | |
| Operating Expenses | $1.8M | $7.6M | $27.7M | $22.2M | $17.8M | |
| Operating Income | -$1.8M | -$6.5M | -$17M | -$8M | -$8M | |
| Net Interest Expenses | -- | $78K | -- | $67K | $49K | |
| EBT. Incl. Unusual Items | -$1.7M | -$6.6M | -$37.4M | -$40.8M | -$9.9M | |
| Earnings of Discontinued Ops. | -- | -- | -$2.3M | -$7.8M | -- | |
| Income Tax Expense | -- | -- | -- | -$1.2M | -$71K | |
| Net Income to Company | -- | -- | -$39.7M | -$47.3M | -$9.8M | |
| Minority Interest in Earnings | $16K | $26K | $53K | $410K | $54K | |
| Net Income to Common Excl Extra Items | -$1.7M | -$6.6M | -$39.6M | -$46.9M | -$9.8M | |
| Basic EPS (Cont. Ops) | -$0.81 | -$3.00 | -$10.55 | -$6.98 | -$0.87 | |
| Diluted EPS (Cont. Ops) | -$0.81 | -$3.00 | -$10.55 | -$7.00 | -$0.87 | |
| Weighted Average Basic Share | $2.1M | $4.2M | $11.1M | $20.3M | $34.5M | |
| Weighted Average Diluted Share | $2.1M | $4.2M | $11.1M | $21M | $34.5M | |
| EBITDA | -$1.7M | -$6.4M | -$15M | -$5.6M | -$9.8M | |
| EBIT | -$1.7M | -$6.5M | -$17M | -$7.7M | -$10.4M | |
| Revenue (Reported) | -- | $3.3M | $23.6M | $58.1M | $46.2M | |
| Operating Income (Reported) | -$1.8M | -$6.5M | -$17M | -$8M | -$8M | |
| Operating Income (Adjusted) | -$1.7M | -$6.5M | -$17M | -$7.7M | -$10.4M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $140K | $15.5M | $37.6M | $8.9M | $4.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $254K | $5.6M | $2.9M | $2M | |
| Inventory | -- | $540K | $3M | $8.7M | $8.5M | |
| Prepaid Expenses | $210K | $347K | -- | -- | -- | |
| Other Current Assets | -- | -- | $1.7M | $805K | $1.4M | |
| Total Current Assets | $461K | $17.6M | $47.9M | $31.2M | $21.4M | |
| Property Plant And Equipment | $435K | $729K | $5M | $3.3M | $1.2M | |
| Long-Term Investments | -- | -- | $2.7M | $730K | -- | |
| Goodwill | -- | $431K | $20.1M | $23.4M | -- | |
| Other Intangibles | $277K | $658K | $9.7M | $17.7M | $946K | |
| Other Long-Term Assets | -- | -- | $97K | $4.7M | $80K | |
| Total Assets | $1.2M | $19.5M | $85.5M | $81M | $23.6M | |
| Accounts Payable | $1.1M | $1.8M | $2.4M | $7.8M | $5.1M | |
| Accrued Expenses | -- | -- | $1.2M | $1.8M | $1.8M | |
| Current Portion Of Long-Term Debt | $1M | $251K | $18K | $1.1M | $1.9M | |
| Current Portion Of Capital Lease Obligations | $53K | $78K | $412K | $1.1M | $799K | |
| Other Current Liabilities | -- | -- | $2M | $5.7M | $6.6M | |
| Total Current Liabilities | $2.2M | $2.7M | $6.1M | $17.4M | $16.3M | |
| Long-Term Debt | -- | $69K | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.5M | $3.2M | $8.5M | $24.6M | $17.2M | |
| Common Stock | $1.4M | $27.3M | -- | -- | -- | |
| Other Common Equity Adj | $23K | $39K | -$1.1M | -$2.7M | -$140K | |
| Common Equity | -$1.3M | $16.4M | $77.2M | $56.8M | $6.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$11K | -$113K | -$225K | -$411K | -- | |
| Total Equity | -$1.3M | $16.3M | $76.9M | $56.4M | $6.4M | |
| Total Liabilities and Equity | $1.2M | $19.5M | $85.5M | $81M | $23.6M | |
| Cash and Short Terms | $140K | $15.5M | $37.6M | $8.9M | $4.4M | |
| Total Debt | -- | $320K | $18K | $1.1M | $1.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $5.9M | $4.8M | $4.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | $3.1M | $2M | $2.6M | |
| Inventory | -- | -- | $10.4M | $10.6M | $7.9M | |
| Prepaid Expenses | -- | -- | $2M | -- | -- | |
| Other Current Assets | -- | -- | -- | $957K | $1M | |
| Total Current Assets | -- | -- | $22.9M | $23.9M | $21.3M | |
| Property Plant And Equipment | -- | -- | $7.6M | $1.8M | $2M | |
| Long-Term Investments | -- | -- | $755K | $200K | -- | |
| Goodwill | -- | -- | $28.9M | -- | $2.2M | |
| Other Intangibles | -- | -- | $12.7M | $5.4M | $3.8M | |
| Other Long-Term Assets | -- | -- | $271K | $285K | $102K | |
| Total Assets | -- | -- | $73.1M | $31.6M | $29.3M | |
| Accounts Payable | -- | -- | $7.6M | $6.7M | $6.7M | |
| Accrued Expenses | -- | -- | $18K | $2M | $3.2M | |
| Current Portion Of Long-Term Debt | -- | -- | $5K | $1.1M | $2.2M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $1.1M | $972K | $832K | |
| Other Current Liabilities | -- | -- | -- | $5.8M | $8M | |
| Total Current Liabilities | -- | -- | $8.7M | $16.6M | $20.9M | |
| Long-Term Debt | -- | -- | $79K | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $19M | $18.5M | $24.1M | |
| Common Stock | -- | -- | $120.2M | -- | -- | |
| Other Common Equity Adj | -- | -- | -$2.7M | -$1.8M | $185K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -$332K | -$1.2M | $937K | |
| Total Equity | -- | -- | $54.2M | $13.1M | $5.2M | |
| Total Liabilities and Equity | -- | -- | $73.1M | $31.6M | $29.3M | |
| Cash and Short Terms | -- | -- | $5.9M | $4.8M | $4.2M | |
| Total Debt | -- | -- | $84K | $1.1M | $2.2M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$14.3M | -$21.4M | -$52.6M | -$56.3M | |
| Depreciation & Amoritzation | -- | $113K | $501K | $2.6M | $2.5M | |
| Stock-Based Compensation | -- | $4.9M | $1.3M | $3.4M | $1.6M | |
| Change in Accounts Receivable | -- | -$472K | -$5.7M | $143K | $1.5M | |
| Change in Inventories | -- | -$55K | -$1.2M | $1.2M | $576K | |
| Cash From Operations | -- | -$8.4M | -$20.9M | -$15.9M | -$8.4M | |
| Capital Expenditures | -- | $234K | $4M | $1.3M | $234K | |
| Cash Acquisitions | -- | -$730K | -$8.1M | -$14.5M | -- | |
| Cash From Investing | -- | -$2.2M | -$14.6M | -$15.8M | -$234K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $6K | -- | $197K | $995K | |
| Long-Term Debt Repaid | -- | -$1.1M | -$302K | -$196K | -$187K | |
| Repurchase of Common Stock | -- | -- | -- | -$255K | -- | |
| Other Financing Activities | -- | -$3.1M | -$5.5M | -$520K | -$396K | |
| Cash From Financing | -- | $25.8M | $58.4M | $4.4M | $3.2M | |
| Beginning Cash (CF) | -- | $140K | $15.5M | $37.6M | $8.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $15.2M | $22.9M | -$27.3M | -$5.5M | |
| Ending Cash (CF) | -- | $15.5M | $37.6M | $8.9M | $4.4M | |
| Levered Free Cash Flow | -- | -$8.7M | -$24.9M | -$17.2M | -$8.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$7.4M | $1.1M | -$3.8M | |
| Depreciation & Amoritzation | -- | -- | $635K | $306K | $226K | |
| Stock-Based Compensation | -- | -- | $162K | $4K | $406K | |
| Change in Accounts Receivable | -- | -- | $107K | $737K | -$789K | |
| Change in Inventories | -- | -- | -$337K | -$2.8M | -$1.5M | |
| Cash From Operations | -- | -- | -$4M | $518K | -$2.1M | |
| Capital Expenditures | -- | -- | $226K | $6K | $20K | |
| Cash Acquisitions | -- | -- | $219K | -- | -- | |
| Cash From Investing | -- | -- | -$7K | -$77K | $236K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -$92K | -$257K | |
| Long-Term Debt Repaid | -- | -- | -$64K | -- | -- | |
| Repurchase of Common Stock | -- | -- | -$5K | -- | -- | |
| Other Financing Activities | -- | -- | -$13K | -$312K | -- | |
| Cash From Financing | -- | -- | -$71K | $2.3M | -$257K | |
| Beginning Cash (CF) | -- | -- | $9.9M | $1.8M | $6.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -$307K | $370K | $184K | |
| Additions / Reductions | -- | -- | -$4.1M | $2.8M | -$2.1M | |
| Ending Cash (CF) | -- | -- | $5.5M | $4.8M | $4.2M | |
| Levered Free Cash Flow | -- | -- | -$4.2M | $512K | -$2.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$60.3M | -$18.8M | |
| Depreciation & Amoritzation | -- | -- | -- | $2.8M | $849K | |
| Stock-Based Compensation | -- | -- | $3.1M | $1.3M | $1M | |
| Change in Accounts Receivable | -- | -- | -- | $1.1M | -$1.8M | |
| Change in Inventories | -- | -- | -- | -$648K | $3.2M | |
| Cash From Operations | -- | -- | -- | -$8.2M | -$4.8M | |
| Capital Expenditures | -- | -- | $949K | $546K | $167K | |
| Cash Acquisitions | -- | -- | -$15.2M | $730K | $64K | |
| Cash From Investing | -- | -- | -- | $113K | $241K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $22K | $1.2M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | $7M | $3.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$1.2M | -$761K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -$8.8M | -$5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$39.7M | -$47.3M | -$9.8M | |
| Depreciation & Amoritzation | -- | -- | $2M | $2.2M | $557K | |
| Stock-Based Compensation | -- | -- | $3.1M | $996K | $428K | |
| Change in Accounts Receivable | -- | -- | $909K | $1.9M | -$1.4M | |
| Change in Inventories | -- | -- | -$1.1M | -$2.9M | -$350K | |
| Cash From Operations | -- | -- | -$15M | -$7.3M | -$3.7M | |
| Capital Expenditures | -- | -- | $949K | $201K | $134K | |
| Cash Acquisitions | -- | -- | -$15.2M | -- | $64K | |
| Cash From Investing | -- | -- | -$16.2M | -$272K | $203K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $212K | $37K | $279K | |
| Long-Term Debt Repaid | -- | -- | -$146K | -- | -- | |
| Repurchase of Common Stock | -- | -- | -$255K | -- | -- | |
| Other Financing Activities | -- | -- | -$88K | -$329K | -$398K | |
| Cash From Financing | -- | -- | -$98K | $2.4M | $3.1M | |
| Beginning Cash (CF) | -- | -- | $62.7M | $16.4M | $14.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -$459K | $954K | $231K | |
| Additions / Reductions | -- | -- | -$31.3M | -$5.1M | -$372K | |
| Ending Cash (CF) | -- | -- | $30.6M | $11.7M | $14.6M | |
| Levered Free Cash Flow | -- | -- | -$15.9M | -$7.5M | -$3.8M | |
Get FLGC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FLGC
Sector
P/E ratio
--
17.73x
PEG ratio
--
0.35x
P/B ratio
4.23x
1.67x
Price / LTM sales
0.18x
0.69x
Growth Metrics
FLGC
Sector
Revenue growth
-28.02%
0.27%
Earnings growth
--
-3.16%
Revenue (5-year growth)
--
4.3%
Earnings forecast
-$0.08
$0.31
Profitability
FLGC
Sector
Profitability FY 2023
$17.7M
$575.2M
Return on invested capital
-211.99%
5.51%
Return on assets
-71.59%
3.55%
Return on equity
-275.22%
8.37%
Earnings Date
Last Earnings Date
Nov
14
Next Earnings Date
May
15
Estimated Next Earnings Date
Feb
13
Balance Sheet
FLGC
Sector
Total cash
$4.2M
$163.2M
Short term investments
--
$53.7M
Total assets
$23.6M
$1.9B
Long term debt
$2.2M
$145.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
